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Abstract 
 
Radiotherapy has been widely use as an adjuvant therapy in the breast cancer management. The usage has increased 
the incidence of radiation induce sarcoma. We here present a case of radiation induce sarcoma of the axilla following 
mastectomy and axillary lymph node dissection for infiltrating ductal carcinoma. 
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Introduction 
 
Radiation induced sarcoma is a late rare complication 
of radiotherapy. The cumulative incidence for radiation 
induced sarcoma has been reported to be 0.07% at 5 
years, 0.27% at 10 years, and 0.48% at 15 years (1).  
We present an interesting case of radiation induced 
sarcoma diagnosed six years later, after completed 
radiotherapy treatment for breast carcinoma. 
 
Case Report 
 
A 58-year-old Chinese lady was diagnosed to have 
invasive ductal carcinoma of the right breast following 
a lumpectomy. She underwent mastectomy and 
axillary lymph node dissection. Histological sections 
of the breast tissue revealed tumour with free margins 
with no axillary lymph nodes metastases. The 
oestrogen and progesterone receptors were negative. 
There was no evidence of distant metastases. She 
underwent six cycles of chemotherapy consisting of 
cyclophosphamide, methotrexate and 5 flurouracil. 
Subsequently, radiation therapy was given to the chest 
wall (at a dose of 40 Gray in 15 fractions). 
Following six years completion of primary treatment, 
she observed a lump progressively increasing in size in 
her right axilla. The lump was painless and did not 
limit the activity of the right upper limb.  Clinical 
examination revealed a fixed hard mass on the right 
axillary region measuring 4 x 4cm overlying the 
previous axillary dissection scar (Fig. 1). Ultrasound 
investigation of the axilla showed a heterogenous 
lesion at the right axilla.  Biopsy confirmed diagnosis 
of high grade sarcoma. Computed tomography of the 
thorax and axilla revealed a mass arising from the right 
axilla which was in close proximity with the latissimus 
dorsi. No nodules were seen in the lung and thorax 
(Fig. 2). Abdominal ultrasound showed no liver 
metastasis and isotope bone scan was normal. 
 
Then, the  patient underwent excision of the tumor and 
intra-operatively noted a hard mass at the right axilla 
measuring 5 x 5 x 4 cm. The mass infiltrated the 
latissimus dorsi. The tumor did not involve the long 
thoracic nerve or the thoracodorsal bundles. No 
enlarged axillary lymph node was detected. Patient 
was discharged well on second post operative day and 
planned for adjuvant chemotherapy and radiotherapy.  
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Figure 1: Fixed hard mass measuring 4x4cm at the previous 
axillary dissesction scar with no evidence of chest wall 
recurrence. Contralateral breast and axilla were normal. 
 
 
 
Figure 2: CT scan showed heterogenous lesion at the right 
axilla with no evidence of distant metastasis (arrow). 
 
Histopathological examination confirmed the 
diagnosis of leiomyosarcoma (Fig. 3). 
 
Discussion 
 
The role of adjuvant radiotherapy in post mastectomy 
patient is well established. It has been proven that 
radiotherapy prevents local recurrence in early breast 
cancer (2).  Despite the benefit of the therapy, radiation 
therapy carries a low risk of sarcoma and the cumulative 
radiation incidence was 0.07%.at 5 years, 27% at 10 
years, and 0.48% at 15 years 1. The criteria for diagnosis 
of radiation induced sarcoma was first described by 
Cahan et al (1998) (3). These criteria were: (a) previous 
history of radiotherapy, (b) asymptomatic history of 
latency period of at least 4 years, (c) sarcoma occurs at 
the previous irradiated site and (d) histological diagnosis. 
The latency period ranges between 2 to 50 years (1). 
Most reports of radiation induced sarcoma were related 
to radiation dose ranging between 60 to 80 Gy (1).   
 
 
Figure 3 : Microscopically the tumor is composed of 
malignant spindle cells which are cigar shaped, 
hyperchromatic, moderately pleomorphic some with 
prominent nucleoli and vesicular chromatin. Pale 
eosinophilic fibrillary cytoplasm are noted which in areas 
show vacuolation. (H&E, original magnification x 60). 
Diagnosis of leiomyosarcoma was made after positive 
immunoreactivity towards vimentin, smooth muscle actin 
(SMA) and desmin. 
 
The diagnosis of soft tissue sarcoma can be 
successfully made by tissue biopsy. The histological 
subtypes and grades can be determined for the vast 
majority of core needle biopsies.  Pathologists who 
have experience  in examining soft tissue sarcoma can 
diagnose it accurately in 95% to 99% of cases, while 
comparing core needle with incisional biopsy 
diagnostic approaches (4). Interestingly, angiosarcoma 
has the highest reported incidence amongst all 
histological subtypes of radiation induced sarcoma 
following breast carcinoma treated by irradiation (5,6).  
Imaging features are not pathognomonic of radiation 
induced sarcoma (7). The current new radiodiagnostic 
imaging modalities of MRI and spiral CT might 
provide adequate information. Three-dimensional 
reconstruction CT enables excellent preoperative 
planning of the extent of the surgical resection and the 
need for reconstruction with plastic surgery, with the 
ultimate goal of achieving an R0 resection with low 
morbidity, e.g., primary wound healing (7,8).  
 
Treatment for radiation induced sarcoma is wide 
surgical resection with immediate reconstruction. In 
order to obtain oncological clearance, surgeons must 
achieve at least 2cm microscopically clear margin (8). 
Chemotherapy and radiotherapy have shown non 
promising results, although doxorubicin and 
ifosfamide has shown modest potential improvement 
in survival (9). Present day research focuses on 
molecular biology basis of the subtype-specific 
oncogene and protein products that could serve as 
treatment targets (10). A five-year survival rate has 
been reported to be 36% and the median survival after 
diagnosis of sarcoma is 34.2 months (1). 
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Conclusion  
 
The vast usage of radiotherapy as an adjunct in breast 
cancer management should be tailored to each patient. 
Although, the incidence of radiation induced sarcoma 
is rare, but clinical suspicion should be considered 
especially in patients presenting with a mass following 
post radiotherapy treatment. 
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